results from a randomized controlled investigation. Abstract #73119. Poster presented at 2026 AAD Annual Meeting; March 27-31, 2026; United States.

Ablon G, et al. The influence of age on relabotulinumtoxinA outcomes in moderate-to-severe glabellar and lateral canthal lines: post-hoc analysis of three phase 3 double-blind, placebo-controlled trials. Abstract #74752. Poster presented at 2026 AAD Annual Meeting; March 27-31, 2026; United States.

Silverberg JI, et al. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus. J Allergy Clin Immunol. 2020;145(1):173-182. doi: 10.1016/j.jaci.2019.08.013.

Nemluvio® U.S. Prescribing Information. Available online. Accessed March 2026.

Nemluvio® European Medicines Agency. Summary of Product Characteristics. Available online. Accessed March 2026.

Zarabian N, et al. Post-isotretinoin acne management: A survey of dermatology practitioners. Abstract #76347.
=*=*=*=*=*=
当前为第15/17页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页